IDiyas

For the Inventor, By the Inventor

Seoul, South Korea

Medexgen Co., Ltd.


USPTO Granted Patents = 4



Forward Citations = 45

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Yong-Hoon Chung (4 out of 5 patents)

silverMedal Ji-Woong Han (3 out of 6 patents)

bronzeMedal Hye-Ja Lee (3 out of 3 patents)

4.  Jin-Mi Kim (3 out of 3 patents)

5.  Eun-Yong Choi (3 out of 3 patents)

6.  Ki-Wan Yi (1 out of 2 patents)

7.  Hak-sup Lee (1 out of 1 patent)

8.  Youn-Hwa Heo (1 out of 1 patent)

9.  Jae-Youn Kim (1 out of 1 patent)

10.  Hak-Sup Lee (0 patent)


4 patents:

1. 8372961 - Polynucleotides encoding concatameric immunoadhesion molecules (2013-02-12),
2. 7670602 - Concatameric immunoadhesion molecule (2010-03-02),
3. 7569361 - Thrombopoietin protein variants (2009-08-04),
4. 7229962 - Tetravalent etanercept (2007-06-12),
Medexgen Co., Ltd. is a leading biotechnology company specializing in the development and commercialization of precision medicine solutions. With a focus on personalized healthcare, Medexgen utilizes genetic testing and advanced analytics to provide tailored treatment options for patients. Our innovative products and services are at the forefront of the healthcare industry, helping to improve outcomes and quality of life for individuals worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#674 in Seoul

#2,085 in South Korea

...
Seoul, South Korea

Medexgen Co., Ltd.

Forward Citations = 45

10 inventors:

goldMedal Yong-Hoon Chung (4 out of 5 patents)

silverMedal Ji-Woong Han (3 out of 6 patents)

bronzeMedal Hye-Ja Lee (3 out of 3 patents)

4.  Jin-Mi Kim (3 out of 3 patents)

5.  Eun-Yong Choi (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…